JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

The silent spread: exploring diverse metastatic pathways in high-grade serous ovarian cancer

  • 0Beijing Obstetrics and Gynecology Hospital, Beijing Maternal and Child Health Care Hospital, Capital Medical University, Beijing, China.
Frontiers in Medicine +

|

March 20, 2025

|

March 20, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

High-grade serous ovarian cancer (HGSOC) spreads through peritoneal, blood, and lymphatic systems. Understanding these metastasis routes and molecular drivers is key to developing effective treatments and improving patient survival.

Area Of Science

  • Oncology
  • Gynecologic Oncology
  • Cancer Metastasis Research

Background

  • High-grade serous ovarian cancer (HGSOC) is a lethal gynecologic malignancy.
  • Metastasis is the primary driver of HGSOC-related mortality.
  • HGSOC spread was traditionally attributed to peritoneal dissemination, but novel routes are emerging.

Purpose Of The Study

  • To review the multifaceted mechanisms of HGSOC metastasis.
  • To highlight the roles of peritoneal immune suppression and stromal reprogramming.
  • To discuss the significance of circulating tumor cells and lymphatic spread.

Main Methods

  • Literature review of HGSOC metastasis.
  • Analysis of peritoneal immune suppression and stromal changes.
  • Examination of blood-based spread via circulating tumor cells.
  • Evaluation of lymphatic metastasis and its clinical impact.

Main Results

  • HGSOC utilizes peritoneal, hematogenous, and lymphatic routes for metastasis.
  • Immune suppression and stromal reprogramming facilitate peritoneal spread.
  • Circulating tumor cells play a critical role in blood-borne metastasis.
  • Lymphatic metastasis significantly impacts patient prognosis.

Conclusions

  • Targeted therapies require understanding HGSOC metastasis pathways.
  • BRCA mutations and immune microenvironment interactions are crucial targets.
  • Future research should focus on improved models, early detection, and novel treatments for HGSOC metastasis.

Keywords:

Related Concept Videos

Metastasis 02:30

5.5K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Tumor Progression 02:07

6.2K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Interactions Between Signaling Pathways 01:19

6.2K

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...